MedTrace Logo

Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs

NCT03767374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2186

Last updated 2024-10-04

No results posted yet for this study

Summary

The aim of this study is to identify risk factors and prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria colonization among patients at high risk of STIs

Conditions

Interventions

PROCEDURE

Inguinal swab sample

Inguinal samples using swab at cross-sectional visit

PROCEDURE

Anal swab sample

Anal samples using swab at cross-sectional visit and at 6-month visit (for those with ESBL and/or CRE colonization)

PROCEDURE

Fecal sample

Fecal sample at cross-sectional visit and at 6-month visit (for those with ESBL and/or CRE colonization)

OTHER

Risk factor assessment

Patients will be asked questions on risk factors associated with MDR/XDR colonization at cross-sectional visit and at 6-month visit (for those with ESBL and/or CRE colonization

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    collaborator OTHER_GOV

  • Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

    lead OTHER

Principal Investigators

  • Laure Surgers, MD · Saint-Antoine Hospital, Paris, France 75012

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-11
Primary Completion
2019-06-30
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03767374 on ClinicalTrials.gov